Gb. Luciani et al., Aortic root replacement in adolescents and young adults: Composite graft versus homograft or autograft, ANN THORAC, 66(6), 1998, pp. S189-S193
Citations number
15
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Background. Aortic root replacement (ARR) is a technically demanding proced
ure that can be performed using a variety of prosthetic devices. Root repla
cement in the young, but grown-up, patient poses unique problems in terms o
f the long-term outcome and active lifestyle that must be guaranteed by thi
s operation. To identify the "ideal" substitute for ARR in the young, clini
cal results in teenagers and young adults (<35 years) operated on in the pa
st two decades were reviewed.
Methods. Thirty-eight patients younger than 35 years underwent ARR between
January 1980 and December 1996. Eighteen patients, aged 30 +/- 5 years, had
ARR with composite graft (group 1), whereas 20 patients, aged 28 +/- 6 yea
rs, had ARR with aortic homografts or pulmonary autografts (group 2). Prima
ry indication for the operation was aortic insufficiency with anuloaortic e
ctasia (12 of 18) in group 1 and aortic insufficiency with or without anulo
aortic ectasia (16 of 20) in group 2. Urgent ARR was required in 3 (17%) gr
oup 1 patients and 1 (5%) group 2 patient (p = 0.01).
Results. Operative deaths were 2 (11%) in group 1, caused by hemorrhage and
low output, and none in group 2. There were 4 (25%) late deaths in group 1
, caused by embolism (2), hemorrhage, and myocardial infarction, and 1 (5%)
in group 2, caused by arrhythmia. Survival was 81% +/- 9%, and 55% +/- 18%
at 2 and 10 years in group 1 versus 94% +/- 5% at 2 years in group 2 (p =
0.04). Freedom from valve-related events was 93% +/- 6% and 62% +/- 18% at
2 and 10 years in group 1 versus 100% at 2 years in group 2 (p = 0.02). Fre
edom from reoperation in group 1 was 75% +/- 22% at 10 years, whereas no re
operations were done in group 2. Seven (58%) group 1 patients versus 1 (5%)
group 2 patient were on cardiac medications (p = 0.001), and 11 (92%) grou
p 1 patients versus no group 2 patients were on warfarin therapy at follow-
up. All survivors were back to school or prior employment.
Conclusions. Survival early after ARR does not differ depending on the type
of prosthesis. Valve-related events are common, and reoperation may be nee
ded late after ARR with composite grafts. Despite limited follow-up with bi
ologic devices, the prevalence of complications with composite grafts makes
homograft or autograft ARR preferable in adolescents and young adults. (C)
1998 by The Society of Thoracic Surgeons.